Loading…

Cannabis use and involuntary admission may mediate long-term adherence in first-episode psychosis patients: a prospective longitudinal study

This study aimed to examine factors associated with treatment adherence in first-episode psychosis (FEP) patients followed up over 8 years, especially involuntary first admission and stopping cannabis use. This prospective, longitudinal study of FEP patients collected data on symptoms, adherence, fu...

Full description

Saved in:
Bibliographic Details
Published in:BMC psychiatry 2013-12, Vol.13 (1), p.326-326, Article 326
Main Authors: Barbeito, Sara, Vega, Patricia, Ruiz de Azúa, Sonia, Saenz, Margarita, Martinez-Cengotitabengoa, Mónica, González-Ortega, Itxaso, Bermudez, Cristina, Hernanz, Margarita, Corres, Blanca Fernández de, González-Pinto, Ana
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c524t-28ceba2a417f05bd1dc5f0334c566d08586475e622e4725820b406de97ccbe813
cites cdi_FETCH-LOGICAL-c524t-28ceba2a417f05bd1dc5f0334c566d08586475e622e4725820b406de97ccbe813
container_end_page 326
container_issue 1
container_start_page 326
container_title BMC psychiatry
container_volume 13
creator Barbeito, Sara
Vega, Patricia
Ruiz de Azúa, Sonia
Saenz, Margarita
Martinez-Cengotitabengoa, Mónica
González-Ortega, Itxaso
Bermudez, Cristina
Hernanz, Margarita
Corres, Blanca Fernández de
González-Pinto, Ana
description This study aimed to examine factors associated with treatment adherence in first-episode psychosis (FEP) patients followed up over 8 years, especially involuntary first admission and stopping cannabis use. This prospective, longitudinal study of FEP patients collected data on symptoms, adherence, functioning, and substance use. Adherence to treatment was the main outcome variable and was categorized as 'good' or 'bad'. Cannabis use during follow-up was stratified as continued use, stopped use, and never used. Bivariate and logistic regression models identified factors significantly associated with adherence and changes in adherence over the 8-year follow-up period. Of the 98 FEP patients analyzed at baseline, 57.1% had involuntary first admission, 74.4% bad adherence, and 52% cannabis use. Good adherence at baseline was associated with Global Assessment of Functioning score (p = 0.019), Hamilton Depression Rating Scale score (p = 0.017) and voluntary admission (p 
doi_str_mv 10.1186/1471-244X-13-326
format article
fullrecord <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3866475</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A534617501</galeid><sourcerecordid>A534617501</sourcerecordid><originalsourceid>FETCH-LOGICAL-c524t-28ceba2a417f05bd1dc5f0334c566d08586475e622e4725820b406de97ccbe813</originalsourceid><addsrcrecordid>eNqNUk2LFDEUbERx19W7Jwl48dJrvrvbg7AMfsGCFwVvIZ28nsnSnbRJemD-w_5o08w67ooHySHhvarivUpV1UuCLwlp5VvCG1JTzn_UhNWMykfV-an0-N77rHqW0g3GpGkFeVqdUU7bruma8-p2o73XvUtoSYC0t8j5fRgXn3U8IG0nl5ILHk36gCawTmdAY_DbOkOcSn8HEbyBwkKDiynXMLsULKA5HcwupCI86-zA5_QOaTTHkGYw2e2PMi4v1nk9olQeh-fVk0GPCV7c3RfV948fvm0-19dfP33ZXF3XRlCea9oa6DXVnDQDFr0l1ogBM8aNkNLiVrSSNwIkpcAbKlqKe46lha4xpoeWsIvq_VF3XvqylCnTRT2qObqpbK2Cduphx7ud2oa9Yq1cpYvAmzuBGH4ukLIqPhkYR-0hLEkR3lFZjJfdf0BlJ1lHBC3Q139Bb8ISiztHFBaSMvkHtdUjKOeHUEY0q6i6EoxL0gi8rnj5D1Q5FiZngofBlfoDAj4STPmiFGE42UGwWsOm1jSpNU2KMFXCViiv7tt4IvxOF_sF9XLRSw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1469056236</pqid></control><display><type>article</type><title>Cannabis use and involuntary admission may mediate long-term adherence in first-episode psychosis patients: a prospective longitudinal study</title><source>Open Access: PubMed Central</source><source>Publicly Available Content Database</source><creator>Barbeito, Sara ; Vega, Patricia ; Ruiz de Azúa, Sonia ; Saenz, Margarita ; Martinez-Cengotitabengoa, Mónica ; González-Ortega, Itxaso ; Bermudez, Cristina ; Hernanz, Margarita ; Corres, Blanca Fernández de ; González-Pinto, Ana</creator><creatorcontrib>Barbeito, Sara ; Vega, Patricia ; Ruiz de Azúa, Sonia ; Saenz, Margarita ; Martinez-Cengotitabengoa, Mónica ; González-Ortega, Itxaso ; Bermudez, Cristina ; Hernanz, Margarita ; Corres, Blanca Fernández de ; González-Pinto, Ana</creatorcontrib><description>This study aimed to examine factors associated with treatment adherence in first-episode psychosis (FEP) patients followed up over 8 years, especially involuntary first admission and stopping cannabis use. This prospective, longitudinal study of FEP patients collected data on symptoms, adherence, functioning, and substance use. Adherence to treatment was the main outcome variable and was categorized as 'good' or 'bad'. Cannabis use during follow-up was stratified as continued use, stopped use, and never used. Bivariate and logistic regression models identified factors significantly associated with adherence and changes in adherence over the 8-year follow-up period. Of the 98 FEP patients analyzed at baseline, 57.1% had involuntary first admission, 74.4% bad adherence, and 52% cannabis use. Good adherence at baseline was associated with Global Assessment of Functioning score (p = 0.019), Hamilton Depression Rating Scale score (p = 0.017) and voluntary admission (p &lt; 0.001). Adherence patterns over 8 years included: 43.4% patients always bad, 26.1% always good, 25% improved from bad to good. Among the improved adherence group, 95.7% had involuntary first admission and 38.9% stopped cannabis use. In the subgroup of patients with bad adherence at baseline, involuntary first admission and quitting cannabis use during follow up were associated with improved adherence. The long-term association between treatment adherence and type of first admission and cannabis use in FEP patients suggest targets for intervention to improve clinical outcomes.</description><identifier>ISSN: 1471-244X</identifier><identifier>EISSN: 1471-244X</identifier><identifier>DOI: 10.1186/1471-244X-13-326</identifier><identifier>PMID: 24289797</identifier><language>eng</language><publisher>England: BioMed Central Ltd</publisher><subject>Adolescent ; Adult ; Antipsychotic Agents - therapeutic use ; Biomedical research ; Care and treatment ; Distance learning ; Drug use ; Female ; Health aspects ; Hospitalization ; Hospitals ; Humans ; Longitudinal Studies ; Male ; Marijuana ; Marijuana Smoking - psychology ; Medication Adherence - psychology ; Mental disorders ; Middle Aged ; Patient compliance ; Prospective Studies ; Psychiatry ; Psychopathology ; Psychoses ; Psychosis ; Psychotic Disorders - diagnosis ; Psychotic Disorders - drug therapy ; Psychotic Disorders - psychology ; Risk factors ; Schizophrenia ; Studies ; Substance abuse ; Suicides &amp; suicide attempts ; Variables</subject><ispartof>BMC psychiatry, 2013-12, Vol.13 (1), p.326-326, Article 326</ispartof><rights>COPYRIGHT 2013 BioMed Central Ltd.</rights><rights>2013 Barbeito et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</rights><rights>Copyright © 2013 Barbeito et al.; licensee BioMed Central Ltd. 2013 Barbeito et al.; licensee BioMed Central Ltd.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c524t-28ceba2a417f05bd1dc5f0334c566d08586475e622e4725820b406de97ccbe813</citedby><cites>FETCH-LOGICAL-c524t-28ceba2a417f05bd1dc5f0334c566d08586475e622e4725820b406de97ccbe813</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC3866475/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1469056236?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/24289797$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Barbeito, Sara</creatorcontrib><creatorcontrib>Vega, Patricia</creatorcontrib><creatorcontrib>Ruiz de Azúa, Sonia</creatorcontrib><creatorcontrib>Saenz, Margarita</creatorcontrib><creatorcontrib>Martinez-Cengotitabengoa, Mónica</creatorcontrib><creatorcontrib>González-Ortega, Itxaso</creatorcontrib><creatorcontrib>Bermudez, Cristina</creatorcontrib><creatorcontrib>Hernanz, Margarita</creatorcontrib><creatorcontrib>Corres, Blanca Fernández de</creatorcontrib><creatorcontrib>González-Pinto, Ana</creatorcontrib><title>Cannabis use and involuntary admission may mediate long-term adherence in first-episode psychosis patients: a prospective longitudinal study</title><title>BMC psychiatry</title><addtitle>BMC Psychiatry</addtitle><description>This study aimed to examine factors associated with treatment adherence in first-episode psychosis (FEP) patients followed up over 8 years, especially involuntary first admission and stopping cannabis use. This prospective, longitudinal study of FEP patients collected data on symptoms, adherence, functioning, and substance use. Adherence to treatment was the main outcome variable and was categorized as 'good' or 'bad'. Cannabis use during follow-up was stratified as continued use, stopped use, and never used. Bivariate and logistic regression models identified factors significantly associated with adherence and changes in adherence over the 8-year follow-up period. Of the 98 FEP patients analyzed at baseline, 57.1% had involuntary first admission, 74.4% bad adherence, and 52% cannabis use. Good adherence at baseline was associated with Global Assessment of Functioning score (p = 0.019), Hamilton Depression Rating Scale score (p = 0.017) and voluntary admission (p &lt; 0.001). Adherence patterns over 8 years included: 43.4% patients always bad, 26.1% always good, 25% improved from bad to good. Among the improved adherence group, 95.7% had involuntary first admission and 38.9% stopped cannabis use. In the subgroup of patients with bad adherence at baseline, involuntary first admission and quitting cannabis use during follow up were associated with improved adherence. The long-term association between treatment adherence and type of first admission and cannabis use in FEP patients suggest targets for intervention to improve clinical outcomes.</description><subject>Adolescent</subject><subject>Adult</subject><subject>Antipsychotic Agents - therapeutic use</subject><subject>Biomedical research</subject><subject>Care and treatment</subject><subject>Distance learning</subject><subject>Drug use</subject><subject>Female</subject><subject>Health aspects</subject><subject>Hospitalization</subject><subject>Hospitals</subject><subject>Humans</subject><subject>Longitudinal Studies</subject><subject>Male</subject><subject>Marijuana</subject><subject>Marijuana Smoking - psychology</subject><subject>Medication Adherence - psychology</subject><subject>Mental disorders</subject><subject>Middle Aged</subject><subject>Patient compliance</subject><subject>Prospective Studies</subject><subject>Psychiatry</subject><subject>Psychopathology</subject><subject>Psychoses</subject><subject>Psychosis</subject><subject>Psychotic Disorders - diagnosis</subject><subject>Psychotic Disorders - drug therapy</subject><subject>Psychotic Disorders - psychology</subject><subject>Risk factors</subject><subject>Schizophrenia</subject><subject>Studies</subject><subject>Substance abuse</subject><subject>Suicides &amp; suicide attempts</subject><subject>Variables</subject><issn>1471-244X</issn><issn>1471-244X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><recordid>eNqNUk2LFDEUbERx19W7Jwl48dJrvrvbg7AMfsGCFwVvIZ28nsnSnbRJemD-w_5o08w67ooHySHhvarivUpV1UuCLwlp5VvCG1JTzn_UhNWMykfV-an0-N77rHqW0g3GpGkFeVqdUU7bruma8-p2o73XvUtoSYC0t8j5fRgXn3U8IG0nl5ILHk36gCawTmdAY_DbOkOcSn8HEbyBwkKDiynXMLsULKA5HcwupCI86-zA5_QOaTTHkGYw2e2PMi4v1nk9olQeh-fVk0GPCV7c3RfV948fvm0-19dfP33ZXF3XRlCea9oa6DXVnDQDFr0l1ogBM8aNkNLiVrSSNwIkpcAbKlqKe46lha4xpoeWsIvq_VF3XvqylCnTRT2qObqpbK2Cduphx7ud2oa9Yq1cpYvAmzuBGH4ukLIqPhkYR-0hLEkR3lFZjJfdf0BlJ1lHBC3Q139Bb8ISiztHFBaSMvkHtdUjKOeHUEY0q6i6EoxL0gi8rnj5D1Q5FiZngofBlfoDAj4STPmiFGE42UGwWsOm1jSpNU2KMFXCViiv7tt4IvxOF_sF9XLRSw</recordid><startdate>20131201</startdate><enddate>20131201</enddate><creator>Barbeito, Sara</creator><creator>Vega, Patricia</creator><creator>Ruiz de Azúa, Sonia</creator><creator>Saenz, Margarita</creator><creator>Martinez-Cengotitabengoa, Mónica</creator><creator>González-Ortega, Itxaso</creator><creator>Bermudez, Cristina</creator><creator>Hernanz, Margarita</creator><creator>Corres, Blanca Fernández de</creator><creator>González-Pinto, Ana</creator><general>BioMed Central Ltd</general><general>BioMed Central</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7TK</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>88G</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M2M</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20131201</creationdate><title>Cannabis use and involuntary admission may mediate long-term adherence in first-episode psychosis patients: a prospective longitudinal study</title><author>Barbeito, Sara ; Vega, Patricia ; Ruiz de Azúa, Sonia ; Saenz, Margarita ; Martinez-Cengotitabengoa, Mónica ; González-Ortega, Itxaso ; Bermudez, Cristina ; Hernanz, Margarita ; Corres, Blanca Fernández de ; González-Pinto, Ana</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c524t-28ceba2a417f05bd1dc5f0334c566d08586475e622e4725820b406de97ccbe813</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Adolescent</topic><topic>Adult</topic><topic>Antipsychotic Agents - therapeutic use</topic><topic>Biomedical research</topic><topic>Care and treatment</topic><topic>Distance learning</topic><topic>Drug use</topic><topic>Female</topic><topic>Health aspects</topic><topic>Hospitalization</topic><topic>Hospitals</topic><topic>Humans</topic><topic>Longitudinal Studies</topic><topic>Male</topic><topic>Marijuana</topic><topic>Marijuana Smoking - psychology</topic><topic>Medication Adherence - psychology</topic><topic>Mental disorders</topic><topic>Middle Aged</topic><topic>Patient compliance</topic><topic>Prospective Studies</topic><topic>Psychiatry</topic><topic>Psychopathology</topic><topic>Psychoses</topic><topic>Psychosis</topic><topic>Psychotic Disorders - diagnosis</topic><topic>Psychotic Disorders - drug therapy</topic><topic>Psychotic Disorders - psychology</topic><topic>Risk factors</topic><topic>Schizophrenia</topic><topic>Studies</topic><topic>Substance abuse</topic><topic>Suicides &amp; suicide attempts</topic><topic>Variables</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Barbeito, Sara</creatorcontrib><creatorcontrib>Vega, Patricia</creatorcontrib><creatorcontrib>Ruiz de Azúa, Sonia</creatorcontrib><creatorcontrib>Saenz, Margarita</creatorcontrib><creatorcontrib>Martinez-Cengotitabengoa, Mónica</creatorcontrib><creatorcontrib>González-Ortega, Itxaso</creatorcontrib><creatorcontrib>Bermudez, Cristina</creatorcontrib><creatorcontrib>Hernanz, Margarita</creatorcontrib><creatorcontrib>Corres, Blanca Fernández de</creatorcontrib><creatorcontrib>González-Pinto, Ana</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Neurosciences Abstracts</collection><collection>ProQuest Health and Medical</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Psychology Database (Alumni)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>PML(ProQuest Medical Library)</collection><collection>Psychology Database (ProQuest)</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>BMC psychiatry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Barbeito, Sara</au><au>Vega, Patricia</au><au>Ruiz de Azúa, Sonia</au><au>Saenz, Margarita</au><au>Martinez-Cengotitabengoa, Mónica</au><au>González-Ortega, Itxaso</au><au>Bermudez, Cristina</au><au>Hernanz, Margarita</au><au>Corres, Blanca Fernández de</au><au>González-Pinto, Ana</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Cannabis use and involuntary admission may mediate long-term adherence in first-episode psychosis patients: a prospective longitudinal study</atitle><jtitle>BMC psychiatry</jtitle><addtitle>BMC Psychiatry</addtitle><date>2013-12-01</date><risdate>2013</risdate><volume>13</volume><issue>1</issue><spage>326</spage><epage>326</epage><pages>326-326</pages><artnum>326</artnum><issn>1471-244X</issn><eissn>1471-244X</eissn><abstract>This study aimed to examine factors associated with treatment adherence in first-episode psychosis (FEP) patients followed up over 8 years, especially involuntary first admission and stopping cannabis use. This prospective, longitudinal study of FEP patients collected data on symptoms, adherence, functioning, and substance use. Adherence to treatment was the main outcome variable and was categorized as 'good' or 'bad'. Cannabis use during follow-up was stratified as continued use, stopped use, and never used. Bivariate and logistic regression models identified factors significantly associated with adherence and changes in adherence over the 8-year follow-up period. Of the 98 FEP patients analyzed at baseline, 57.1% had involuntary first admission, 74.4% bad adherence, and 52% cannabis use. Good adherence at baseline was associated with Global Assessment of Functioning score (p = 0.019), Hamilton Depression Rating Scale score (p = 0.017) and voluntary admission (p &lt; 0.001). Adherence patterns over 8 years included: 43.4% patients always bad, 26.1% always good, 25% improved from bad to good. Among the improved adherence group, 95.7% had involuntary first admission and 38.9% stopped cannabis use. In the subgroup of patients with bad adherence at baseline, involuntary first admission and quitting cannabis use during follow up were associated with improved adherence. The long-term association between treatment adherence and type of first admission and cannabis use in FEP patients suggest targets for intervention to improve clinical outcomes.</abstract><cop>England</cop><pub>BioMed Central Ltd</pub><pmid>24289797</pmid><doi>10.1186/1471-244X-13-326</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1471-244X
ispartof BMC psychiatry, 2013-12, Vol.13 (1), p.326-326, Article 326
issn 1471-244X
1471-244X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3866475
source Open Access: PubMed Central; Publicly Available Content Database
subjects Adolescent
Adult
Antipsychotic Agents - therapeutic use
Biomedical research
Care and treatment
Distance learning
Drug use
Female
Health aspects
Hospitalization
Hospitals
Humans
Longitudinal Studies
Male
Marijuana
Marijuana Smoking - psychology
Medication Adherence - psychology
Mental disorders
Middle Aged
Patient compliance
Prospective Studies
Psychiatry
Psychopathology
Psychoses
Psychosis
Psychotic Disorders - diagnosis
Psychotic Disorders - drug therapy
Psychotic Disorders - psychology
Risk factors
Schizophrenia
Studies
Substance abuse
Suicides & suicide attempts
Variables
title Cannabis use and involuntary admission may mediate long-term adherence in first-episode psychosis patients: a prospective longitudinal study
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T16%3A27%3A51IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Cannabis%20use%20and%20involuntary%20admission%20may%20mediate%20long-term%20adherence%20in%20first-episode%20psychosis%20patients:%20a%20prospective%20longitudinal%20study&rft.jtitle=BMC%20psychiatry&rft.au=Barbeito,%20Sara&rft.date=2013-12-01&rft.volume=13&rft.issue=1&rft.spage=326&rft.epage=326&rft.pages=326-326&rft.artnum=326&rft.issn=1471-244X&rft.eissn=1471-244X&rft_id=info:doi/10.1186/1471-244X-13-326&rft_dat=%3Cgale_pubme%3EA534617501%3C/gale_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c524t-28ceba2a417f05bd1dc5f0334c566d08586475e622e4725820b406de97ccbe813%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1469056236&rft_id=info:pmid/24289797&rft_galeid=A534617501&rfr_iscdi=true